Short Title:
Mars 600/900 Sim II
Responsible HRP Element:
Space Radiation
Funding Status:
Planned-Funded - Task expected to be within budget
|
Procurement Mechanism(s):
|
|
Aims:
Specific Aims:
-
Aim 1 (Cancer): Determine impact of a simulated 600 day Mars mission exposure on radiation carcinogenesis including tumor burden, spectrum, latency, progression, and aggressiveness.
-
-
Aim 2 (Cancer): Determine impact of a simulated 900 day Mars mission exposure, including complex secondary environment found on Mars Surface, on radiation carcinogenesis including tumor burden, spectrum, latency, progression, and aggressiveness.
-
-
Aim 3 (CVD/CNS): Determine impact of a simulated 600 day Mars mission exposure on cardiovascular and late neurodegenerative CNS diseases.
-
-
Aim 4 (CVD/CNS): Determine impact of a simulated 900 day Mars mission exposure, including complex secondary environment found on Mars Surface cardiovascular and late neurodegenerative CNS diseases.
-
-
Aim 5 (Cross Risk): Validate biomarker approaches for in mission surveillance during Mars 600 and 900 mission simulation.
-
Studies will focus on doses and dose rates seen on a 600 day free space transit simulating Mars flyby or opposition-class, short stay mission as well as a 900 day conjunction-class, long stay mission on the surface of Mars.
Category:
Risk Characterization, Quantification
Subcategory:
Evidence or Risk Characterization
Description:
Radiobiology data sets (mixed field quality and dose rate dependence) to validate risk prediction models for simulated Mars Missions.
Internal Customers:
None
External Customers:
None